Screener
Eli Lilly
LLYEli Lilly and Company is a global pharmaceutical leader focused on the discovery, development, manufacturing, and marketing of innovative human medicines.
Earnings
Next report
Oct 29, 2026 (in 2 months)Revenue estimate$22.1B
EPS estimate$9.85
Valuation & ratios
Segments
Competitors
By market cap
By revenue growth
Profile
Eli Lilly and Company is a global pharmaceutical leader focused on the discovery, development, manufacturing, and marketing of innovative human medicines. The company specializes in high-growth therapeutic areas including cardiometabolic health, oncology, immunology, and neuroscience. Its core value proposition centers on delivering differentiated treatments that improve patient outcomes and provide value to global healthcare payers.
Competitive position
A leading global innovator in the pharmaceutical industry with a dominant position in the diabetes and anti-obesity markets.
GeographiesUnited States, Europe, Asia, China
Customer segmentsHealthcare providers, Wholesale distributors, Government health agencies, Patients
Business modelR&D-driven manufacturing, Direct-to-patient digital health, B2B wholesale distribution
SuppliersRaw material suppliers, Contract research organizations, Third-party manufacturing partners, Academic research institutions
CustomersMcKesson Corporation, Cencora, Inc., Cardinal Health, Inc., Pharmacy Benefit Managers, Hospitals, Retail Pharmacies
CountryUnited States of America
Listed1970
Employees43.0K
CEODavid A. Ricks
SectorHealthcare
IndustryDrug Manufacturers - General
Websitelilly.com
FilingsSEC EDGAR
FAQ
- What is Eli Lilly's market cap?
- Eli Lilly (LLY) has a market capitalization of $1.06T and trades on NYSE.
- What is Eli Lilly's revenue and profitability?
- Eli Lilly generated $79.7B in trailing twelve-month revenue with net income of $26.7B, representing a net margin of 33.5%. Gross margin stands at 83.4%, with free cash flow of $18.2B. These figures are based on the Q2 2026 filing.
- Who are Eli Lilly's competitors?
- Eli Lilly's key competitors include Pfizer Inc., Amgen Inc., McKesson Corporation, and others. These companies compete in similar markets and product categories.
- Who does Eli Lilly partner with?
- Eli Lilly's notable partners include Boehringer Ingelheim, Incyte Corporation, Innovent Biologics, Inc., and others.
- Where is Eli Lilly headquartered?
- Eli Lilly is headquartered in United States of America and employs approximately 43,000 people. It has been publicly traded since 1970.
